Kuboyama Tomoharu
Division of Neuromedical Science, Institute of Natural Medicine, University of Toyama;
J Vis Exp. 2018 Oct 30(140). doi: 10.3791/58229.
Amyloid-β (Aβ) causes memory impairments in Alzheimer's disease (AD). Although therapeutics have been shown to reduce Aβ levels in the brains of AD patients, these do not improve memory functions. Since Aβ aggregates in the brain before the appearance of memory impairments, targeting Aβ may be inefficient for treating AD patients who already exhibit memory deficits. Therefore, downstream signaling due to Aβ deposition should be blocked before AD development. Aβ induces axonal degeneration, leading to the disruption of neuronal networks and memory impairments. Although there are many studies on the mechanisms of Aβ toxicity, the source of Aβ toxicity remains unknown. To help identify the source, we propose a novel protocol that uses microscopy, gene transfection, and live cell imaging to investigate early changes caused by Aβ in axonal growth cones of cultured neurons. This protocol revealed that Aβ induced clathrin-mediated endocytosis in axonal growth cones followed by growth cone collapse, demonstrating that inhibition of endocytosis prevents Aβ toxicity. This protocol will be useful in studying the early effects of Aβ and may lead to more efficient and preventative AD treatment.
淀粉样蛋白β(Aβ)会导致阿尔茨海默病(AD)患者出现记忆障碍。尽管已证明治疗方法可降低AD患者大脑中的Aβ水平,但这些方法并不能改善记忆功能。由于Aβ在记忆障碍出现之前就在大脑中聚集,因此针对Aβ治疗已出现记忆缺陷的AD患者可能效率低下。因此,应在AD发展之前阻断Aβ沉积引起的下游信号传导。Aβ会诱导轴突变性,导致神经网络破坏和记忆障碍。尽管关于Aβ毒性机制的研究很多,但Aβ毒性的来源仍然未知。为了帮助确定来源,我们提出了一种新颖的方案,该方案使用显微镜、基因转染和活细胞成像来研究Aβ在培养神经元轴突生长锥中引起的早期变化。该方案表明,Aβ在轴突生长锥中诱导网格蛋白介导的内吞作用,随后生长锥塌陷,这表明抑制内吞作用可防止Aβ毒性。该方案将有助于研究Aβ的早期作用,并可能导致更有效和预防性的AD治疗。